Rare Disease Patients Benefit from Clinical Trial Flexibility

November 10, 2022 

    • Tags:

Francis Jones, Ph.D., Tim Rich, and Meredith McCumbee, experts in the Thermo Fisher Scientific Research Business supporting PPD Digital and Decentralized Solutions, discuss how digital and decentralized clinical trial solutions offer greater flexibility to benefit rare disease patients.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: